Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
Study: 2.5% of Americans have food allergy

Study: 2.5% of Americans have food allergy

Biogen, Elan announce clinical utility data of two-step ELISA to detect anti-JCV antibodies

Biogen, Elan announce clinical utility data of two-step ELISA to detect anti-JCV antibodies

Food allergies are becoming more common in U.S. children

Food allergies are becoming more common in U.S. children

Alkermes' VIVITROL medication for treatment of opioid dependence

Alkermes' VIVITROL medication for treatment of opioid dependence

ACE educational program launched to promote awareness on anaphylaxis

ACE educational program launched to promote awareness on anaphylaxis

Childcare centers address food allergies of ethnically diverse population

Childcare centers address food allergies of ethnically diverse population

Amgen to present oncology portfolio results at ESMO Congress

Amgen to present oncology portfolio results at ESMO Congress

Xeomin botulinum toxin for cervical dystonia now available in the U.S.

Xeomin botulinum toxin for cervical dystonia now available in the U.S.

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

IDMC recommends early termination of Phase 3 intramuscular depot aripiprazole trial

Egg allergies may be prevented by early introduction: Study

Egg allergies may be prevented by early introduction: Study

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Scientists identify a new way to cure food allergies

Scientists identify a new way to cure food allergies

Precautionary guidelines on flu vaccine safety for allergic children

Precautionary guidelines on flu vaccine safety for allergic children

Emergency treatment of anaphylaxis with epinephrine by trained non-medical professionals endorsed

Emergency treatment of anaphylaxis with epinephrine by trained non-medical professionals endorsed

Children with food allergies experience bullying: Study

Children with food allergies experience bullying: Study

Biogen Idec concurs with FDA on safety monitoring for Gilenya through REMS

Biogen Idec concurs with FDA on safety monitoring for Gilenya through REMS

Savient's KRYSTEXXA receives FDA approval for chronic gout in adult patients refractory to conventional therapy

Savient's KRYSTEXXA receives FDA approval for chronic gout in adult patients refractory to conventional therapy

Biogen to publish data on two-step assay for anti-JC virus antibody detection

Biogen to publish data on two-step assay for anti-JC virus antibody detection

Baxter announces definitive agreement with Kamada for GLASSIA alpha1-proteinase inhibitor

Baxter announces definitive agreement with Kamada for GLASSIA alpha1-proteinase inhibitor

FDA accepts Salix's XIFAXAN550 sNDA for Priority Review

FDA accepts Salix's XIFAXAN550 sNDA for Priority Review